|
|
4047
|
DYRADE M SUSPENSION
|
DILOXANIDE METRONIDAZOLE
|
LORDS HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
4809
|
DYRADE M TABLET
|
DILOXANIDE FUROATE & METRONIDAZOLE
|
LORDS HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
13227
|
DYRADE M TABLETS
|
DILOXANIDE FUROATE BP AND METRONIDAZOLE BP
|
LORDS HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
CTD6416
|
DYRAGYL 250/200
|
DILOXANIDE FUROATE BP, METRONIDAZOLE BP
|
KRISHNA CHEMISTS LTD
|
Registered
|
Details →
|
|
|
CTD6417
|
DYRAGYL DS 500/400
|
DILOXANIDE FUROATE BP, METRONIDAZOLE BP
|
KRISHNA CHEMISTS LTD
|
Registered
|
Details →
|
|
|
H2010/22787/868
|
DYRASUN
|
METRONIDAZOLE + DILOXAMIDE FUROATE
|
ZAWADI HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
22717
|
DYRASUN DF
|
DILOXAMIDE FUROATE + METRONIDAZOLE
|
ZAWADI HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
H2010/22675/196
|
DYRASUN SUSPENSION
|
METRONIDAZOLE + DILOXANIDE FUROATE
|
ZAWADI HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
H2011/22236/221
|
DYSEN FORTE TABLET
|
SECNIDAZOLE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2020/CTD5665/1473ER
|
DYSEN SUSPENSION
|
SECNIDAZOLE
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9512/21667
|
DYSMIN INJECTION
|
HYOSCINE BUTYLBROMIDE INJECTION BP 20MG/ML
|
PRO MED PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9339/21230
|
DYSMIN SYRUP
|
EACH 5.0ML CONTAINS: HYOSCINE BUTYLBROMIDE BP 5.0 MG
|
PRO MED PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9467/21231
|
DYSMIN TABLETS
|
HYOSCINE BUTYLBROMIDE BP……..10 MG
|
ZAIN PHARMA LIMITED
|
Registered
|
Details →
|
|
|
CTD9118
|
DYZOL DS
|
DILOXANIDE FUROATE AND METRONIDAZOLE
|
SIGNATURE HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9118/20230
|
DYZOL DS
|
Diloxanide furoate and Metronidazole
|
MOHAMED IFTIKHAR SAEED
|
Retained
|
Details →
|
|
|
H2006/264 (15443)/R1
|
Dafraclav 457 mg suspension
|
Amoxicillin Clavulanic acid
|
Dafra Pharma GmbH
|
Retained
|
Details →
|
|
|
H2007/776/R1
|
Dalacin C 150mg
|
Clindamycin hydrochloride
|
Pfizer Laboratories Limited
|
Retained
|
Details →
|
|
|
H2001/0444/14011/R1
|
Dalacin C 300mg
|
Clindamycin hydrochloride
|
Pfizer Laboratories Limited
|
Retained
|
Details →
|
|
|
H2007/778/R1
|
Dalacin C injection
|
Clindamycin phosphate
|
Pfizer Laboratories Limited
|
Retained
|
Details →
|
|
|
-
|
Dalacin T 1% solution
|
Clindamycin phosphate
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|